We are your partner in drug development

Buy Phentermine 37.5 mg Pills from Burrard Pharma

How Phentermine 37.5 mg-Suppresses your Appetite

Nowadays, weight loss is easier to accomplish because there are a number of diet pills that are available in the market today that can aid individuals in sustaining their diet. Among the most reliable ones are Adipex and Phenterime diet pills. Both drugs can help you in controlling the amount of food you eat by controlling your appetite. Prescriptions for Phentermine 37.5 is no longer required when you get it, and they will not hurt your finances. Simply use the internet and obtain the most trustworthy diet pill store to assist you and your Phentermine 37.5 will be shipped immediately.

Drug Name: Phentermine (Generic Adipex)
Tablet Strength: 37.5 mg blue/white pills
Available Packages: 20, 40, 60, 90, 120, 160, 200 pills
Payment Method: VISA, MASTERCARD
Shipment: Express Depvery Service
Buy Now From: NoRxPharmaStore


Without putting in effort, Phentermine 37.5 will not be able to help you have the figure that you always dreamed of. There is no short cut to wellness that is why adequate nutritional intake and exercise should be maintained. It is best to talk to your doctor first before you start using this medicine, for you to know how Phentermine can affect your health, and for them to effectively create a diet program that will suit your needs. Generally, decreasing carbohydrate consumption and taking in more fruits and vegetables are the best places to start. Ensure that your diet plan is coupled with a good exercise routine. If you need to find out what is the best workout and exercise level for you, then seek for a reputable resource facility online. Those information you have successfully obtained can assist you in making an exercise plan that will fit you best. Ensure that you are comfortable with the diet plan that you pick because it's the only way you can be sure that you will maximize its benefit. It would be a good idea to ask appropriate inquiries, to be sure that you understand everything. Accomplishment in diet program is only attained when you certainly understood its every aspect. Before you include it in what you eat, ensure that you are aware of the right way to store and use the medication, along with the adverse reactions that could probably happen when using Phentermine. Using these steps, you can easily use Phentermine 37.5 for your diet plan and reach the perfect weight you have always desired in no time at all. Modifying your diet plan will really enable you to slim down successfully. Are you conscious on your weight? Regulate your desire for food, and reduce excess weight with the aid of Adipex Diet. Efficient suppression and control of desire for food is achievable due to the Phentermine that is incorporated into Adipex Diet pills. Keep in mind that Adipex diet pill is utilized for short-term remedy for obesity.

Happy Customers Experience

  • This service is excellent. It's quick and easy. It even adjusted my payment for my without holding up my shipment if I made an error.
  • Online pharmacies were something I was skeptical of. You proved me wrong. We are grateful to you. You are prompt, discreet, and very affordable.
  • This is a great place to buy your medication. Low prices and fast service! This is my new pharmacy
  • It was a great experience to get the Rx I needed at a significant discount compared with my local pharmacy. The customer service response time was also exceptional. I will definitely be returning to you!
  • Burrard Pharma was the first time I tried it. It was a few years ago that I couldn't believe how much my insurance covered for one of my generic medications. I did my research on the company to see how they could offer this medication at a lower price. It was also easy to transfer my prescription. My order was processed quickly and was exactly the same medication that I received from the pharmacy. Honeybee has been recommended to me by many of my family members and friends. I am sure they will enjoy the same wonderful experience.
  • We have over a
    decade of experience
    in pharmaceuticals.

    We have the knowledge and expertise to complete almost any kind of drug formulations.

    Services

    Meet our team
    with partners from all over the world

    Dr. Kayhan Moayeri (CEO)

    Read More

    Dr. Kayhan Moayeri is an entrepreneurial pharmacist who specializes in business development and drug discovery with two decades of experience. As CEO of Amerix Pharmaceutical, Dr. Moayeri combines his unique experience in both business and the pharmaceutical industry to oversee the quality operations of the company. Prior to founding Amerix Pharmaceutical, Dr. Moayeri worked at Sanofi, a French multinational pharmaceutical company and a global healthcare leader that is highly focused on patient needs. He then found Amerix Pharmaceutical to head up their global business development division. Dr. Moayeri is an expert in drug formulation, drug discovery, and contract manufacturing. Over the last few years, he has masterminded contract manufacturing projects worth eight figures of Canadian dollars. Dr. Moayeri holds a Doctor of Philosophy in Pharmacy from Azad University and a Master of Business Administration from University of Nebraska-Lincoln.

    Dr. Sandip Kaur Badyal

    Read More

    Dr Sandip Kaur Badyal obtained a PhD in Biological Chemistry from the University of Leicester after which she joined the lab of Professor Bagshaw on a joint venture research project with Dr Kriajevska to study the effects of mobile cells during metastasis. From a relatively short but successful research period, Dr Badyal has 9 publications in peer reviewed journals.

    Dr Badyal decided to move into the field of Regulatory Affairs to pursue her passion to use her scientific knowledge to help others. Whilst mastering the skills of the Regulatory Affairs profession she co-partnered a Regulatory Affairs consultancy in Hamburg, Germany for 3 years. Where she proficiently and successfully worked on the lifecycle management and registering of numerous pharmaceutical products exceeding client expectations.

    Dr Badyal moved to Vancouver, BC, Canada and continues to provide Regulatory Affairs consultancy services whilst also branching out into the field of Medical Devices.

    Dr. Colin Collins

    Read More

    Dr. Collins obtained a PhD in Medical Genetics from the University of British Columbia after which he became faculty at Lawrence Berkeley National Laboratory (LBNL). At LBNL Dr. Collins was a cofounder of the Resource for Molecular Cytogenetics in the Department of Life Sciences. In 1998 Dr. Collins moved to the University of California San Francisco’s (UCSF) Comprehensive Cancer Center. At UCSF Dr. Collins invented and patented “paired end sequencing” and was the first to sequence a tumor genome. He also was the first to show that genome copy number aberrations can be used to risk stratify men with prostate cancer for metastasis. This work also received a patent. In 2009 Dr. Collins relocated to the University of British Columbia (UBC) and the Vancouver Prostate Centre (VPC). At the VPC Dr. Collins Directs the Laboratory for Advanced Genome Analysis (LAGA) and the BGI-VPC Joint Research Laboratory. These support genome and computational biology research within the VPC, Canada and internationally. It also supports a precision oncology program at the VPC. Dr. Collins has a keen interest in treatment resistant prostate cancer where he and his collaborators have made key discoveries into the mechanisms of therapeutic resistance, identification of novel therapeutic targets and the development of liquid biopsies for prostate and other cancers. Dr. Collins has appointments at Simon Fraser University in the School of Computing Science and at BGI in the Think Tank Division. He has over 190 publications and multiple patents.

    Dr. Gary Woodnutt

    Read More

    Recently Dr. Woodnutt has acted as a Consultant to several small Companies in both the Research and Development area to critically evaluate their ongoing projects as well as to provide planning and oversight for Development projects. Dr. Woodnutt served as CSO of Lpath until December 2016 where he led all Discovery and Development activities concerning the exploitation of monoclonal antibodies to bioactive lipids. Prior to that, Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX from 2012 to 2013, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.

    Luca Citton

    Read More

    Luca functions as external legal counsel to Burrard Pharmaceuticals

    Luca Citton is a Shareholder and member of the Board of Directors of Boughton Law. Practicing primarily in the areas of Corporate and Commercial Law, he advises clients on the structuring, sale and continuing operation of a range of businesses, from small and medium enterprises through to national and multinational corporations.

    His extensive client base includes companies in the entertainment, food and beverage, manufacturing, professional services and technology sectors. In addition to corporate and commercial law, Luca maintains an ancillary practice in IP law and is a registered Canadian Trademark Agent.

    Timothy Morris

    Read More

    Mr. Morris brings over 32 years of professional finance and accounting experience and 20 years as a chief financial officer to the Burrard Advisory Board. Mr. Morris has held several CFO roles most recently as chief financial officer and head of business development for AcelRx Pharmaceuticals, a biotechnology company focusing on the development and commercialization of products for the treatment of moderate-to-severe acute pain in medically supervised settings.

    Previous to joining AcelRx, Mr. Morris held the positions of chief financial officer at VIVUS, Inc and Questcor Pharmaceuticals. During his career as CFO, he raised over $980 million in equity and convertible securities for 5 different companies. He has extensive deal experience, having completed over 70 transactions with a combined value in excess of $2.0 billion.

    His work at late-stage biotechnology companies have provided him with valuable experience in regulatory filings and product launches. He has been involved with 4 NDA approvals and applications (including the pending application for DSUVIA, AcelRx’s lead candidate), and 2 MAA approvals (one for ZALVISO, AcelRx’s follow-on candidate, which is approved in Europe). His commercial experience includes the launch of QSYMIA an innovative metabolic small molecule and preparations for the launch of DSUVIA in the US.

    He also serve of the Board of Directors for KaloBios, (KBIO), a biopharmaceutical company focused on rare and orphan disease and on PAION, Inc, the US subsidiary of PAION AG.

    Dr. Patricia-Ann Truter

    Read More

    Dr. Patricia-Ann Truter is a Material Scientist with more than 22 years of product and research and development experience. Her education includes a PhD in Polymer science (Thesis: “The Chemical Development of a Hydrogel to be used as an Artificial Skin”), a MSc in Chemistry (Thesis: “Hydroxy methylation of Kraft Lignin for Novel Adhesive Applications”) and a BSc (Main subjects: Chemistry and Human Physiology). She also attended a 6-week intensive short course: on water soluble polymers at MIT, Boston, USA.

    Patricia is a professional, technical manager with extensive experience in formulation, biomaterial and product development, technology transfer from idea, development, scale up, clinical trials and commercialization (liquids, parenterals, coatings, solid dosage forms. implants, topical products, hydrogels, etc.). She is the inventor and author of > 20 patents, publications, presentations and posters.

    Patricia’s work experience range from Vice President and Chief Scientific Officer: R&D (ARC Medical Devices, Vancouver, BC), Director: R&D (Kisameet, Vancouver, BC), Director: Drug Delivery and Biomaterials (Angiotech Pharmaceuticals, Vancouver, BC,) and a Board member of Ellipsoid Technologies (Pretoria, South Africa). Patricia has worked closely and was involved in technology transfers, clinical batch manufacture with international pharmaceutical companies such as Ethypharm, Abbott Laboratories, SA Druggists and Pfizer.

    Why work with us?

    Experience

    Multicultural

    Innovation

    Get in touch!

    2240 Chippendale Rd West Vancouver,
    BC V7S 3J5

    +1-778-279-3901/ +1-844-9-PHARMA

    Or send us a message